Ian Marshall
Pediatric Endocrinology New Brunswick, NJ Medical Doctor
NPI 1396760450 CMS profile 245135
89 French Street, Pediatric Endocrinology Suite 2300, New Brunswick, NJ 08901
General payments
$51,385
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$113,433
Through program year 2025, Ian Marshall of New Brunswick, NJ is reported in the CMS Open Payments database as having received $51,385 across 60 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $113,433 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 92nd percentile of Pediatric Endocrinology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $31,791 | 20 | |
| 2024 | General | $13,793 | 30 | |
| 2023 | General | $905 | 6 | |
| 2022 | General | $72 | 2 | |
| 2021 | General | $4,730 | 1 | |
| 2020 | General | $94 | 1 |
Beside peers
- Ian Marshall
- Pediatric Endocrinology median
- Middle half of Pediatric Endocrinology
- National median
In program year 2025, general payments to Ian Marshall were reported at $31,791. Among 971 Pediatric Endocrinology profiles paid that year, the median was $293 and the middle half received between $106 and $1,640.
Show as a table
| Year | Ian Marshall | Pediatric Endocrinology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $196 | $68–$845 | $163 |
| 2020 | $94 | $124 | $37–$722 | $114 |
| 2021 | $4,730 | $134 | $35–$691 | $132 |
| 2022 | $72 | $177 | $47–$726 | $149 |
| 2023 | $905 | $236 | $75–$887 | $160 |
| 2024 | $13,793 | $259 | $91–$979 | $164 |
| 2025 | $31,791 | $293 | $106–$1,640 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
60 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Endocrinology in New Jersey
Lawrence Silverman
Pediatric Endocrinology · Morristown, NJ
Ahmed Khattab
Pediatric Endocrinology · New Brunswick, NJ
Dennis Brenner
Pediatric Endocrinology · West Orange, NJ
Eric Huang
Pediatric Endocrinology · Basking Ridge, NJ
Irene Mamkin
Pediatric Endocrinology · West Orange, NJ
Elizabeth Burtman
Pediatric Endocrinology · Tenafly, NJ
Related records
Pediatric Endocrinology in New Jersey
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Endocrinology
Everyone recorded under this specialty, nationwide.
Doctors in New Jersey
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.